Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report

  • Yukinori Ozaki1, 3Email authorView ORCID ID profile,
  • Junichi Shindoh2, 3,
  • Yuji Miura1,
  • Hiromichi Nakajima1,
  • Ryosuke Oki1,
  • Miyuki Uchiyama1,
  • Jun Masuda1,
  • Keiichi Kinowaki4,
  • Chihiro Kondoh1,
  • Yuko Tanabe1,
  • Tsuyoshi Tanaka5,
  • Shusuke Haruta5,
  • Masaki Ueno5,
  • Shigehisa Kitano6,
  • Takeshi Fujii4,
  • Harushi Udagawa5 and
  • Toshimi Takano1
BMC Cancer201717:778

https://doi.org/10.1186/s12885-017-3785-4

Received: 8 February 2017

Accepted: 14 November 2017

Published: 21 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
8 Feb 2017 Submitted Original manuscript
21 Jul 2017 Reviewed Reviewer Report - Frances Collichio
31 Jul 2017 Reviewed Reviewer Report - Thomas Eigentler
6 Sep 2017 Author responded Author comments - Yukinori Ozaki
Resubmission - Version 2
6 Sep 2017 Submitted Manuscript version 2
11 Sep 2017 Reviewed Reviewer Report - Thomas Eigentler
13 Sep 2017 Reviewed Reviewer Report - Frances Collichio
28 Sep 2017 Author responded Author comments - Yukinori Ozaki
Resubmission - Version 3
28 Sep 2017 Submitted Manuscript version 3
4 Oct 2017 Author responded Author comments - Yukinori Ozaki
Resubmission - Version 4
4 Oct 2017 Submitted Manuscript version 4
11 Nov 2017 Author responded Author comments - Yukinori Ozaki
Resubmission - Version 5
11 Nov 2017 Submitted Manuscript version 5
Publishing
14 Nov 2017 Editorially accepted
21 Nov 2017 Article published 10.1186/s12885-017-3785-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Medical Oncology, Toranomon Hospital
(2)
Hepatobiliary-pancreatic Surgery Division, Department of Digestive Surgery, Toranomon Hospital
(3)
Okinaka Memorial Institute for Medical Disease
(4)
Department of Pathology, Toranomon Hospital
(5)
Department of Gastroenterological Surgery, Toranomon Hospital
(6)
Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center

Advertisement